OnKure Therapeutics CEO Saccomano sells $357 in stock
Corroborated by 2 sources from 2 publishers
middle_eastbusiness3h ago
TL;DR
Reports differ across sources; according to finance.yahoo.com, executives from LENZ Therapeutics (NASDAQ:LENZ) used the company’s latest earnings call to provide an update on the early U.S.